Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CHemab Therapeutics Holdings, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

Hemab Therapeutics Holdings, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Sep 24, 2026Walbert KeliDirector36,000Stock Option (Right to Buy)$1.5MGrant / award
Jun 16, 2026RA CAPITAL MANAGEMENT, L.P.10% Owner61,523Common Stock$1.5MBuy
Jun 15, 2026RA CAPITAL MANAGEMENT, L.P.10% Owner6,146Common Stock$153.5KBuy
May 20, 2026RA CAPITAL MANAGEMENT, L.P.10% Owner996Common Stock$28KBuy
May 19, 2026RA CAPITAL MANAGEMENT, L.P.10% Owner3,802Common Stock$106.7KBuy
May 12, 2026RA CAPITAL MANAGEMENT, L.P.10% Owner6,387Common Stock$160.4KBuy
May 11, 2026RA CAPITAL MANAGEMENT, L.P.10% Owner39,869Common Stock$1MBuy
May 8, 2026RA CAPITAL MANAGEMENT, L.P.10% Owner1,483Common Stock$37.3KBuy
May 7, 2026RA CAPITAL MANAGEMENT, L.P.10% Owner9,906Common Stock$336.8KBuy
May 6, 2026RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner68,018Common Stock$2.3MBuy
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • Insider Transactions
$30.89Close ยท Oct 8, 2026